Depression, Brain Implants, and the False Divide Between Psychoanalysis and Neuroscience

A recent study out of the University of Minnesota has generated considerable interest within the mental health community. Researchers reported on a man who had suffered from severe treatment-resistant depression for nearly thirty years. After multiple unsuccessful interventions, he underwent an experimental procedure known as Personalized Adaptive Cortical Electro-stimulation (PACE).

Unlike traditional neuromodulation approaches, PACE does not target the same brain region in every patient. Instead, researchers first mapped the individual’s neural networks to identify the specific circuits associated with his depressive symptoms. Electrodes were then implanted on the surface of the cortex and adjusted over time according to his responses.

The results were striking. Within seven weeks, the patient’s suicidal thoughts had reportedly disappeared. Within nine months, his depression was considered to be in remission, and the improvement was maintained thirty months later.

Although the findings are limited to a single case and should be interpreted cautiously, the study raises important questions about how psychological suffering is understood and treated. It also highlights a longstanding tension within psychology itself: the relationship between biological and psychological explanations of human distress.

One response to the study that I encountered reflected a concern that has existed within psychoanalytic circles for decades. The commenter suggested that the patient’s improvement may have been largely attributable to placebo effects and the considerable hope invested in a highly personalized and technologically sophisticated intervention. Drawing a comparison to psychedelic-assisted therapy, the commenter argued that lasting change ultimately depends not on biological intervention alone but on processes such as integration, symbolization, and psychological working-through. The implication was that if depression is fundamentally psychological in origin, then interventions directed primarily at the brain may have limited capacity to address its underlying causes.

This perspective deserves careful consideration. Psychoanalysis has long served as an important corrective to purely biological models of mental suffering. Depression cannot be adequately understood as a malfunctioning neural circuit in the same way that a broken bone can be understood as a damaged piece of anatomy. Human suffering is embedded within developmental history, attachment relationships, unconscious conflict, personal meaning, and social and cultural context. Psychoanalytic clinicians have therefore been understandably skeptical of theories that attempt to reduce complex psychological phenomena to biological mechanisms alone.

At the same time, I believe the PACE study exposes a limitation that can emerge within some psychodynamic critiques of biological interventions. In emphasizing the importance of meaning, psychoanalysis can sometimes inadvertently preserve the very mind-body split it seeks to overcome. The argument that depression originates in the psyche rather than the brain assumes that these are separate domains that can be meaningfully distinguished from one another. Yet contemporary neuroscience, somatic psychology, and even psychoanalysis itself offer reasons to question this assumption.

Historically, the relationship between psychoanalysis and neuroscience has been more intertwined than many realize. Freud began his career as a neurologist and never abandoned the view that psychological experience was grounded in biological processes. Psychoanalysis emerged not because Freud rejected the brain, but because the neuroscience of his time lacked the tools necessary to investigate the neural mechanisms underlying subjective experience. In many respects, psychoanalytic theory developed as an attempt to understand mental life at a level of analysis that nineteenth-century biology could not yet access.

The contemporary landscape looks quite different. Advances in neuroscience increasingly describe depression not as the product of a single dysfunctional brain region but as a disturbance within complex networks that integrate emotion, attention, memory, self-referential processing, and interpersonal functioning. Interestingly, this systems-oriented perspective bears a greater resemblance to psychodynamic thinking than either field often acknowledges. Both traditions increasingly recognize that human experience emerges from dynamic interactions among multiple processes rather than from isolated causes.

This is why I find the placebo critique less convincing than it initially appears. The concept of placebo is often invoked as though it provides an alternative explanation to biological change. In reality, placebo effects demonstrate the profound ways in which meaning and expectation influence biological systems. Hope, trust, anticipation, and belief are not disembodied psychological events. They are lived experiences that correspond with measurable changes in neural activity, physiology, and behavior. To suggest that an intervention worked because of placebo rather than because of biology may therefore create a distinction that is far less clear than it seems.

A similar issue emerges in discussions of psychedelic-assisted therapy. While many advocates emphasize the importance of preparation and integration, few would argue that the neurobiological effects of psychedelics are irrelevant. Likewise, it would be difficult to argue that the biological effects alone fully account for therapeutic outcomes. Increasingly, the evidence suggests that psychological and biological processes are not competing explanations but different descriptions of the same phenomenon viewed from different levels of analysis.

The PACE study may ultimately invite a similar reframing. Rather than asking whether the intervention worked because it altered the brain or because it altered the patient’s psychological experience, it may be more useful to consider how these processes influence one another. Changes in neural organization may affect a person’s capacity for emotional regulation, reflection, attachment, and meaning-making. Conversely, psychological experiences alter neural organization continuously throughout life.

The relationship is reciprocal rather than unidirectional.

From an embodied perspective, this reciprocity is unavoidable. Every thought, memory, fantasy, emotion, and relational experience occurs through a living body. Likewise, neural activity never exists apart from subjective experience. The distinction between brain and psyche remains useful as a conceptual tool, but it becomes increasingly problematic when treated as an ontological reality. Human beings do not possess separate psychological and biological lives. These are different ways of describing a single integrated process.

For this reason, I suspect the most significant implication of this study is not that depression has finally been located in the brain, nor that psychoanalytic understandings of suffering have somehow been displaced by neuroscience. Rather, the study highlights the limitations of framing biological and psychological explanations as competitors. Both contemporary neuroscience and contemporary psychodynamic theory increasingly point toward a more integrated understanding of human experience — one in which brain, body, relationships, meaning, and subjective life are inseparable aspects of the same living system.

As a single case study, the PACE intervention tells us very little about whether this treatment will ultimately prove effective for large numbers of people. What it does offer, however, is an opportunity to revisit some of psychology’s oldest assumptions.

The most interesting question raised by this case may not be whether depression is biological or psychological, but whether that distinction remains as useful as we once believed.